Synthesis of 6,6‐ and 7,7‐difluoro‐1‐acetamidopyrrolizidines and their oxidation catalyzed by the nonheme Fe oxygenase LolO

Nabin Panth,Eliott S. Wenger,Carsten Krebs,J. Martin Bollinger,Robert B. Grossman
DOI: https://doi.org/10.1002/cbic.202200081
IF: 3.2
2022-04-28
ChemBioChem
Abstract:LolO, a 2‐oxoglutarate‐dependent nonheme Fe oxygenase, catalyzes both the hydroxylation and cycloetherification of 1‐ exo ‐acetamidopyrrolizidine (AcAP), a pathway intermediate in the biosynthesis of the loline alkaloids. We have prepared fluorinated AcAP analogs to aid in continued mechanistic investigation of the unusual LolO‐catalyzed cycloetherification step. LolO was able to first hydroxylate and then cycloetherify 6,6‐difluoro‐AcAP (prepared from N , O ‐protected 4‐oxoproline), forming a difluorinated analog of N ‐acetylnorloline (NANL) and providing evidence for a cycloetherification mechanism involving a C(7) radical as opposed to a C(7) carbocation. By contrast, LolO was able to hydroxylate 7,7‐difluoro‐AcAP (prepared from 3‐oxoproline) but failed to cycloetherify it, forming (1 R , 2 R , 8 S )‐7,7‐difluoro‐2‐hydroxy‐AcAP as the sole product. Because it completely blocks the cycloetherification step, 7,7‐difluoro‐AcAP has the potential to become an important tool for accumulating and characterizing the LolO intermediate responsible for catalyzing cycloetherification of 2‐hydroxy‐AcAP.
biochemistry & molecular biology,chemistry, medicinal
What problem does this paper attempt to address?